Today: 9 June 2026
GitLab stock whipsaws: GTLB holds gains in premarket after 13% surge
23 January 2026
2 mins read

GitLab stock whipsaws: GTLB holds gains in premarket after 13% surge

New York, Jan 23, 2026, 05:04 ET — Premarket

  • Before the bell, GitLab shares gained roughly 0.5%, trading near $37.60.
  • The stock surged 12.8% in the previous session, rebounding sharply from a fresh 52-week low.
  • Recent SEC filings reveal that GitLab’s incoming CFO and CTO do not hold any beneficial ownership in the company’s securities.

GitLab Inc shares (GTLB.O) ticked up slightly in premarket trading on Friday, building on a strong bounce that pushed the DevSecOps software company over 12% higher the day before. The stock hovered near $37.60, up roughly 0.5%.

The move is significant since GitLab has hovered near its lows, and Thursday’s late-session rebound came suddenly, even by recent measures. Traders will be looking to see if the bounce sticks when U.S. cash trading kicks off or if it’s just a brief pause after the drop.

On Thursday, GitLab’s shares bounced sharply, hitting a low around $32.92—a fresh 52-week low—before rallying to an intraday high of $37.53. The stock closed at $37.40, with trading volume exceeding its recent average, data showed.

New filings have once again highlighted management turnover, a lingering issue since late 2025, though Thursday’s rally lacked a clear catalyst.

GitLab’s new CFO, Jessica P. Ross, filed a Form 3 insider ownership disclosure showing she currently owns no securities. The filing is dated Jan. 15 and was signed on Jan. 22.

A separate Form 3 filed for GitLab’s new chief technology officer, Sivaprasad Padisetty, showed the same “no securities are beneficially owned” disclosure. The form is dated Jan. 15 and was signed on Jan. 22. https://www.sec.gov/Archives/edgar/data/16…

GitLab announced earlier this month that Siva Padisetty will step in as CTO on Jan. 15, taking over from Sabrina Farmer. Farmer has stepped down but will stay on as an adviser until Jan. 31. CEO Bill Staples dubbed Padisetty “the engineer’s CTO,” while Padisetty emphasized that the AI opportunity goes beyond just speeding up code. https://ir.gitlab.com/news/news-details/20…

In its most recent quarterly filing from December, the company reported $244.4 million in revenue for the quarter ending Oct. 31, marking a 25% increase compared to the same period last year. It also provided guidance for both the current quarter and the full fiscal year.

GitLab offers tools for building, securing, and shipping software. In this space, customers demand clearer returns from AI features but remain budget-conscious. Competitors include Microsoft-owned GitHub in code collaboration and various enterprise software companies providing developer tools.

That rebound might not hold. One choppy session won’t answer the persistent doubts investors have — can GitLab reignite growth, retain its biggest clients, and maintain pricing power while rivals roll out more comprehensive bundled offerings?

Traders are now waiting on an official date for GitLab’s next earnings release. While market calendars peg the report around March 2, the company hasn’t confirmed that yet.

Stock Market Today

  • AmpliTech Shares Surge 26.7% on 5G Open RAN Testing Update
    June 9, 2026, 9:16 AM EDT. AmpliTech (AMPG) shares surged 26.7% to $6.57 following its Open RAN testing update at the O-RAN Alliance Global PlugFest Spring 2026. The company's 64T64R Massive MIMO radio, which uses multiple antennas to enhance wireless capacity, was the only one of its kind tested with equipment from major operators including AT&T and Deutsche Telekom. Despite the strong test results, no new sales orders were announced, leaving investors cautious about future revenue impact. AmpliTech reported a 48.6% increase in first-quarter revenue to $5.35 million but remains unprofitable, narrowing its net loss to $1.52 million. The firm holds $18.4 million in cash and securities. Open RAN aims to enable multi-vendor interoperability in 5G networks, a critical push in telecom infrastructure modernization.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Experian share price rebounds after bruising slide as traders weigh Q3 update and policy risk
Previous Story

Experian share price rebounds after bruising slide as traders weigh Q3 update and policy risk

Novo Nordisk stock price jumps before the bell as Wegovy pill prescriptions leap
Next Story

Novo Nordisk stock price jumps before the bell as Wegovy pill prescriptions leap

Go toTop